To test the efficacy of B P Care Tablets in patients having Hypertension.

An open Label, Single arm Clinical Study to Evaluate the efficacy of Shuddhi Dr. B P Care Tablets in patients having Hypertension. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2025/08/092262

Enrollment

Registered

2025-08-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I119- Hypertensive heart disease withoutheart failure

Interventions

Intervention1: Shuddhi Dr. B P Tablets: Dose: 1-1 Tablet (BD) Route of Administration: Oral Duration : 1 day Control Intervention1: Not Applicable: Not Applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject from 18-50 years of age. 2. Subject having BP range less than 180-120 or 100-109 will be eligible for enrollment. 3. Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study. 4. Subject willing to avoid participation in any other interventional clinical trial for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including oral or parenteral corticosteroids. 2. Subject will not enroll with BP range higher than 180-120 or 100-109. 3. Subjects that have participated in any other interventional clinical trial in the previous 90 days. 4. Subjects with known sensitivity to any of the constituents of the investigational product. 5. Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures. 6. Chronic illness which may influence the outcome of the study. 7. Pregnant/nursing mothers

Design outcomes

Primary

Measure	Time frame
1. Reduction in BP calculated as Change in the Systolic and Diastolic Blood pressure Timepoint: At t0min, t30min, t1hs, t2hrs, t3hrs, t4hrs, t5hrs and t6hrs	—

Secondary

Measure	Time frame
1. Change in Heart Rate 2. Change in SGA (Subject Global Assessment) Score [0-3] such as Severe Headache, Chest pain, Difficulty breathing, Anxiety and Dizziness [t0min and t6hrs] Timepoint: At t0min, t30min, t1hrs, t2hrs, t3hrs, t5hrs and t6hrs	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026